ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 48 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALGERT GLOBAL LLC | 124,891 | $85,000 | 0.04% |
Icahn Capital | 5,904,863 | $4,030,000 | 0.01% |
SEIZERT CAPITAL PARTNERS, LLC | 414,810 | $283,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 473,708 | $323,000 | 0.01% |
Anson Funds Management LP | 25,000 | $17,000 | 0.01% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 106,908 | $72,000 | 0.01% |
Spark Investment Management LLC | 57,500 | $39,000 | 0.01% |
Renaissance Technologies | 3,501,585 | $2,390,000 | 0.01% |
Concert Wealth Management Inc. | 45,938 | $30,000 | 0.00% |
CSS LLC/IL | 96,572 | $66,000 | 0.00% |